For The Latest Medical News, Health News, Research News, COVID-19 News, Pharma News, Glaucoma News, Diabetes News, Herb News, Phytochemical News, Thailand Cannabis News, Cancer News, Doctor News, Thailand Hospital News, Oral Cancer News, Thailand Doctors

BREAKING NEWS
Nikhil Prasad  Fact checked by:Thailand Medical News Team Nov 30, 2025  1 month, 2 weeks, 1 day, 19 hours, 56 minutes ago

Fisetin Shows Promise Against Deadly Brain Cancer or Glioblastoma

5714 Shares
facebook sharing button Share
twitter sharing button Tweet
linkedin sharing button Share
Fisetin Shows Promise Against Deadly Brain Cancer or Glioblastoma
Nikhil Prasad  Fact checked by:Thailand Medical News Team Nov 30, 2025  1 month, 2 weeks, 1 day, 19 hours, 56 minutes ago
Medical News: Growing Attention on a Natural Plant Compound
A new study led by scientists from Poznan University of Medical Sciences in Poland and Adam Mickiewicz University is drawing global attention to fisetin, a natural plant flavonoid found in strawberries, apples and onions. Researchers found that this simple dietary molecule may hold powerful anticancer effects against glioblastoma, one of the deadliest and most treatment-resistant brain tumors. According to this Medical News report, glioblastoma patients typically survive less than a year even with surgery, radiation and chemotherapy, making the discovery of any new therapeutic pathway extremely important.


New research shows fisetin may offer a powerful new strategy against aggressive brain tumors
 
How Fisetin Attacks Glioblastoma Cells
The research team conducted detailed laboratory tests on human U-138 MG glioblastoma cells and revealed that fisetin strongly disrupts cancer cell growth. At higher concentrations, fisetin forced tumor cells into a form of cell cycle arrest, slowing their ability to copy DNA and divide. Even more significantly, fisetin triggered apoptosis, the natural self-destruction pathway that cancer cells often avoid. At just 25 micromolar, fisetin pushed more than 42 percent of glioblastoma cells into apoptosis, and at 50 micromolar nearly three-quarters of the cancer cells were destroyed. These results were stronger than the effects of topotecan, a known chemotherapy drug used as a positive control in the study.
 
Nanoparticles Improve Delivery and Potency
One of the biggest challenges with fisetin is its poor solubility and instability, which make it difficult to use as a medicine. To overcome this, the researchers developed special PLGA nanoparticles designed to carry fisetin more effectively into the body. The most successful formulation created particles around 330 nanometers in size with high drug-loading efficiency of over 83 percent. Lab tests showed that these fisetin-loaded nanoparticles significantly improved the compound’s cancer-killing effects. At higher doses, tumor cell survival dropped to as low as 9 percent while the empty nanoparticles themselves showed no toxicity.
 
Fisetin Survives Sterilization and Remains Chemically Stable
Another positive finding came from examining how fisetin behaves during radiation sterilization, a requirement for injectable medicines. Even after being exposed to standard sterilization levels, fisetin maintained its chemical integrity. While very high radiation doses caused temporary molecular changes, no permanent structural damage or harmful by-products were detected. This indicates that fisetin can be safely prepared for medical use without losing its therapeutic properties.
 
Outlook for Future Treatments
The study highlights fisetin as a strong candidate for future glioblastoma therapy, especially when delivered using advanced nanoparticles that enhance its stability and effectiveness. Although these results are early and limited to laboratory cell models, they suggest that fisetin could one day be developed into an injectable treatment that complements or strengthens existing chemotherapy options.
 
Continued research exploring how these nanoparticles move through the body, cross the blood-brain barrier and interact with tumor tissue will be essential. If future animal and clinical studies confirm these effects, fisetin could offer new hope for patients facing a cancer that currently has few effective long-term treatments.
 
The study findings were published in the peer reviewed journal: Polymers.
https://www.mdpi.com/2073-4360/17/22/3074
 
For the latest on Brain Cancer, keep on logging to Thailand Medical News.
 
Read Also:
https://www.thailandmedical.news/articles/cancer
 
https://www.thailandmedical.news/articles/herbs-and-phytochemicals
 

MOST READ

Jan 13, 2026  3 days ago
Nikhil Prasad
Jan 12, 2026  4 days ago
Nikhil Prasad
Jan 12, 2026  4 days ago
Nikhil Prasad
Jan 11, 2026  5 days ago
Nikhil Prasad
Jan 08, 2026  8 days ago
Nikhil Prasad
Jan 07, 2026  9 days ago
Nikhil Prasad
Jan 06, 2026  10 days ago
Nikhil Prasad
Jan 05, 2026  11 days ago
Nikhil Prasad
Jan 04, 2026  12 days ago
Nikhil Prasad
Jan 04, 2026  12 days ago
Nikhil Prasad
Jan 03, 2026  13 days ago
Nikhil Prasad
Jan 01, 2026  15 days ago
Nikhil Prasad
Dec 31, 2025  16 days ago
Nikhil Prasad
Dec 30, 2025  17 days ago
Nikhil Prasad
Dec 27, 2025  20 days ago
Nikhil Prasad
Dec 25, 2025  22 days ago
Nikhil Prasad
Dec 24, 2025  23 days ago
Nikhil Prasad

FROM THAILAND HOSPITAL NEWS

LATEST ON CARDIOLOGY